4//SEC Filing
Giuffre Randall Michael 4
Accession 0001759822-26-000002
CIK 0001401040other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 5:24 PM ET
Size
6.7 KB
Accession
0001759822-26-000002
Insider Transaction Report
Form 4
Giuffre Randall Michael
Director
Transactions
- Award
Common Stock
2026-01-02$8.42/sh+6,175$51,994→ 398,587 total
Holdings
- 25,573(indirect: See footnote)
Common Stock
- 21,070(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]Shares are issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. Amended and Restated 2019 Omnibus Incentive Plan, in lieu of cash retainer fees in the aggregate amount of $52,000. The deferred stock units are scheduled to vest in four nearly equal installments on each of March 31, June 30, September 30, and December 31, 2026.
- [F2]These voting common shares are held by 424822 Albert Ltd, of which Michael Giuffre has sole voting and dispositive power.
Documents
Issuer
DiaMedica Therapeutics Inc.
CIK 0001401040
Entity typeother
Related Parties
1- filerCIK 0001759822
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 5:24 PM ET
- Size
- 6.7 KB